Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')

被引:81
|
作者
Ricaurte, GA
McCann, UD
Szabo, Z
Scheffel, U
机构
[1] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21224 USA
[2] Johns Hopkins Med Inst, Dept Psychiat, Baltimore, MD 21224 USA
[3] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21224 USA
关键词
serotonin; neurotoxicity; amphetamines; PET; transporters; 3,4-methylenedioxy-methamphetamine;
D O I
10.1016/S0378-4274(99)00216-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The recreational drug, (+/-)3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), is a potent serotonin (5-HT) neurotoxin in animals. Whether humans who use MDMA incur 5-HT neural injury is unknown. The present studies utilized positron emission tomography (PET) in conjunction with the 5-HT transporter ligand, [C-11]McN-5652 to assess the status of brain 5-HT neurons in human MDMA users. Like nonhuman primates treated with neurotoxic doses of MDMA, humans with a history of MDMA use showed lasting decrements in global brain [C-11]McN-5652 binding, with decreases in [C-11]McN-5652 binding positively correlated to the extent of previous MDMA use. These results suggest that human MDMA use results in brain 5-HT neurotoxicity. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [21] The Acute Psychobiological Impacts of Illicit 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') Consumption in Recreational Environments
    Morefield, K. M.
    Keane, M.
    Felgate, P.
    White, J. M.
    Irvine, R. J.
    [J]. NEUROPSYCHOBIOLOGY, 2009, 60 (3-4) : 216 - 216
  • [22] A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation
    Mechan, AO
    O'Shea, E
    Elliott, JM
    Colado, MI
    Green, AR
    [J]. PSYCHOPHARMACOLOGY, 2001, 155 (04) : 413 - 418
  • [23] A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation
    Annis O. Mechan
    Esther O'Shea
    Martin J. Elliott
    Maria Colado
    Richard A. Green
    [J]. Psychopharmacology, 2001, 155 : 413 - 418
  • [24] Multiple toxicity from 3,4-methylenedioxymethamphetamine ("Ecstasy")
    Greene, SL
    Dargan, PI
    O'Connor, N
    Jones, AL
    Kerins, M
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2003, 21 (02): : 121 - 124
  • [25] Validating the consumption of MDMA (3,4-methylenedioxymethamphetamine) in an examination of the behavioural effects of "ecstasy" amongst recreational users
    Sherlock, K
    Hay, AWM
    Wolff, K
    Conner, M
    [J]. ADDICTION RESEARCH, 1999, 7 (01): : 47 - 62
  • [26] Cerebral 1H MRS alterations in recreational 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") users
    Chang, L
    Ernst, T
    Grob, CS
    Poland, RE
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 1999, 10 (04) : 521 - 526
  • [27] TOXICITY AND DEATHS FROM 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY)
    HENRY, JA
    JEFFREYS, KJ
    DAWLING, S
    [J]. LANCET, 1992, 340 (8816): : 384 - 387
  • [28] Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)
    Wieckiewicz, Gniewko
    Danel, Dariusz
    Piegza, Magdalena
    Gorczyca, Piotr
    Pudlo, Robert
    [J]. PSYCHIATRIA POLSKA, 2022, 56 (05) : 1109 - 1130
  • [29] 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, 'ECSTASY'): GENDER DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS
    Pardo-Lozano, R.
    Farre, M.
    Yubero-Lahoz, S.
    Torrens, M.
    Mustata, C.
    Perez-Mana, C.
    Menoyo, E.
    Perez, M.
    Martin, S.
    Cuyas, E.
    Civit, E.
    O'Mathuna, B.
    Carbo, M.
    de la Torre, R.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 51 - 52
  • [30] Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'')
    Cohen, RS
    Cocores, J
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (04): : 727 - 734